NationalIntranasal Booster Doses Against Covid-19 Are Easy To Administer | What Are These?BY Outlook Web Desk
NationalBharat Biotech's Intranasal Booster Dose Gets DCGI's Approval For Phase-3 TrialsBY Outlook Web Desk
NationalCovid-19 Vaccine For Teenagers: DCGI Grants Emergency Authorisation To CovaxinBY Outlook Web Desk
BusinessThe Jab Of Life: Covaxin’s Success Proves Bharat Biotech Was On Right PathBY Outlook Web Desk
NationalCovaxin Gets WHO Nod For Emergency Use: What That Means For Indian TravelersBY Outlook Web Desk
NationalCovaxin: WHO Panel Recommends Emergency Use Listing Status For Bharat Biotech's Covid VaccineBY Outlook Web Desk
NationalCovaxin: Bharat Biotech's Covid-19 Shot Gets Shelf Life Extension Up To 12 MonthsBY Outlook Web Desk
NationalAustralia Recognises Covaxin: All Countries That Have Approved Bharat Biotech's Covid-19 VaccineBY Outlook Web Desk
NationalCovaxin: 7 Countries Allowing Entry To Indians Vaccinated With Bharat Biotech's Covid-19 ShotBY Outlook Web Desk
Making A DifferenceCovid-19 Vaccine: Oman Approves Bharat Biotech's Covaxin Under New Travel RulesBY Outlook Web Desk
NationalWHO Technical Group To Meet On Oct 26 To Consider EUL Of Bharat Biotech’s CovaxinBY Outlook Web Desk
NationalRevised Covishield Monthly Production Likely To be More Than 120 Million, Covaxin 58 Million: Health MinisterBY Outlook Web Desk
NationalGovt Expects 4 More Indian Pharma Brands To Begin Vaccine Production By Oct-Nov: Health MinisterBY Outlook Web Desk
NationalCovaxin Provides Protection Against Delta Plus Covid Variant: ICMR StudyBY Outlook Web Bureau
Making A DifferenceBrazil Suspends Covaxin’s Clinical Trials After Bharat Biotech Ends Deal With Precisa MedicamentosBY Outlook Web Bureau
.jpg?auto=format%2Ccompress&fit=max&format=webp&w=300&dpr=1.0)
